Controversy

Can imaging/radiomics reliably infer HPV status or predict outcome in oropharyngeal carcinoma?

Evidence profile

Status: awaiting_review. Rule: atlas-profile-2.0.

5 linked publications; not a count of independent studies.

Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.

Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).

Position A

Radiomic/multimodal ML classifiers report high AUCs for HPV status and treatment response

Position B

Models are overwhelmingly internal-validation-only, single-center, and not externally validated; imaging cannot replace p16/HPV testing

Clinical stakes

Premature imaging-based HPV assignment could misdirect de-escalation trials; the endpoint (HPV) already has a reference test.

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Editorial lead: Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Page generated 2026-10-02. This is not a new clinical review date.

This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.